Log In
Print
BCIQ
Print
Print this Print this
 

Argamate granule, calcium polystyrene sulfonate

  Manage Alerts
Collapse Summary General Information
Company Sanwa Kagaku Kenkyusho Co. Ltd.
DescriptionGranular formulation of Argamate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyperkalemia
Indication DetailsTreat hyperkalemia
Regulatory Designation

Partner

Astellas Pharma Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today